Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
25
GALT Quote, Financials, Valuation and Earnings
Last price:
$4.03
Seasonality move
:
25.89%
Day range:
$3.90 - $4.06
52-week range:
$0.76 - $7.13
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
247.4K
Avg. volume:
636.3K
1-year change:
379.42%
Market cap:
$259.8M
Revenue:
--
EPS (TTM):
-$0.59
Galectin Therapeutics, Inc. SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
GALT
Galectin Therapeutics, Inc.
|
05/15/2024 | 10-Q | 10-Q filing on 05/15/2024 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
11/13/2023 | 10-Q | 10-Q filing on 11/13/2023 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
08/14/2023 | 10-Q | 10-Q filing on 08/14/2023 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
05/15/2023 | 10-Q | 10-Q filing on 05/15/2023 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
11/14/2022 | 10-Q | 10-Q filing on 11/14/2022 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
08/15/2022 | 10-Q | 10-Q filing on 08/15/2022 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
05/16/2022 | 10-Q | 10-Q filing on 05/16/2022 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
11/15/2021 | 10-Q | 10-Q filing on 11/15/2021 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
08/16/2021 | 10-Q | 10-Q filing on 08/16/2021 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
05/17/2021 | 10-Q | 10-Q filing on 05/17/2021 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
11/09/2020 | 10-Q | 10-Q filing on 11/09/2020 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
08/10/2020 | 10-Q | 10-Q filing on 08/10/2020 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
05/11/2020 | 10-Q | 10-Q filing on 05/11/2020 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
11/12/2019 | 10-Q | 10-Q filing on 11/12/2019 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
08/09/2019 | 10-Q | 10-Q filing on 08/09/2019 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
05/10/2019 | 10-Q | 10-Q filing on 05/10/2019 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
11/13/2018 | 10-Q | 10-Q filing on 11/13/2018 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
09/28/2018 | 10-Q | 10-Q filing on 09/28/2018 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
08/14/2018 | 10-Q | 10-Q filing on 08/14/2018 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
05/11/2018 | 10-Q | 10-Q filing on 05/11/2018 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
11/07/2017 | 10-Q | 10-Q filing on 11/07/2017 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
08/14/2017 | 10-Q | 10-Q filing on 08/14/2017 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
05/15/2017 | 10-Q | 10-Q filing on 05/15/2017 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
11/08/2016 | 10-Q | 10-Q filing on 11/08/2016 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
08/09/2016 | 10-Q | 10-Q filing on 08/09/2016 | View Form |
|
GALT
Galectin Therapeutics, Inc.
|
05/10/2016 | 10-Q | 10-Q filing on 05/10/2016 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
68
KOD alert for Dec 25
Kodiak Sciences, Inc. [KOD] is up 13.41% over the past day.
Buy
64
ZCSH alert for Dec 25
Grayscale Zcash Trust (ZEC) [ZCSH] is up 5.33% over the past day.
